These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32350593)

  • 1. Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR).
    Jazayeri MH; Aghaie T; Nedaeinia R; Manian M; Nickho H
    Cancer Immunol Immunother; 2020 Sep; 69(9):1833-1840. PubMed ID: 32350593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine detection of survivin and diagnosis of bladder cancer.
    Smith SD; Wheeler MA; Plescia J; Colberg JW; Weiss RM; Altieri DC
    JAMA; 2001 Jan; 285(3):324-8. PubMed ID: 11176843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a New Survivin ELISA and UBC
    Gleichenhagen J; Arndt C; Casjens S; Meinig C; Gerullis H; Raiko I; Brüning T; Ecke T; Johnen G
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
    Eissa S; Badr S; Barakat M; Zaghloul AS; Mohanad M
    Clin Lab; 2013; 59(7-8):893-900. PubMed ID: 24133921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies.
    Chen D; Xu J; Zhang Q
    Oncol Rep; 2018 Jun; 39(6):2817-2828. PubMed ID: 29658613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies.
    Jazayeri MH; Amani H; Pourfatollah AA; Avan A; Ferns GA; Pazoki-Toroudi H
    Cancer Gene Ther; 2016 Oct; 23(10):365-369. PubMed ID: 27740614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
    Eissa S; Badr S; Elhamid SA; Helmy AS; Nour M; Esmat M
    Dis Markers; 2013; 34(1):57-62. PubMed ID: 22960341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer.
    Zhang Z; Wang S; Xu H; Wang B; Yao C
    J Biomed Opt; 2015 May; 20(5):51043. PubMed ID: 26021715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic alterations of adenomatous polyposis coli (APC), retinoic acid receptor beta (RARβ) and survivin genes in tumor tissues and voided urine of bladder cancer patients.
    Berrada N; Amzazi S; Ameziane El Hassani R; Benbacer L; El Mzibri M; Khyatti M; Chafiki J; Abbar M; Al Bouzidi A; Ameur A; Attaleb M
    Cell Mol Biol (Noisy-le-grand); 2012 Sep; Suppl.58():OL1744-51. PubMed ID: 22992440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
    Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
    East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder cancer detection with urinary survivin, an inhibitor of apoptosis.
    Sharp JD; Hausladen DA; Maher MG; Wheeler MA; Altieri DC; Weiss RM
    Front Biosci; 2002 Feb; 7():e36-41. PubMed ID: 11815300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.
    Shariat SF; Casella R; Khoddami SM; Hernandez G; Sulser T; Gasser TC; Lerner SP
    J Urol; 2004 Feb; 171(2 Pt 1):626-30. PubMed ID: 14713774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
    Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance.
    Yuan J; Duan R; Yang H; Luo X; Xi M
    Int J Nanomedicine; 2012; 7():2921-8. PubMed ID: 22745553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR.
    Yahyazadeh R; Bashash D; Ghaffari P; Kord S; Safaroghli-Azar A; Ghaffari SH
    BMC Urol; 2021 Apr; 21(1):64. PubMed ID: 33874920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic role of survivin in urinary bladder cancer.
    Srivastava AK; Singh PK; Srivastava K; Singh D; Dalela D; Rath SK; Goel MM; Brahma Bhatt ML
    Asian Pac J Cancer Prev; 2013; 14(1):81-5. PubMed ID: 23534808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
    Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
    Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
    J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin: role in diagnosis, prognosis, and treatment of bladder cancer.
    Akhtar M; Gallagher L; Rohan S
    Adv Anat Pathol; 2006 May; 13(3):122-6. PubMed ID: 16778475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.